Vitality Biopharma, Inc. (VBIO)
Market Closed
15 Oct, 08:00 PM
EXPM EXPM Primary $
1. 23
-0.22
-15.1724%
$
6.01M Market Cap
- P/E Ratio
- Div Yield
13.56M Volume
- Eps
$ 1.45
Previous Close Want to track VBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vitality Biopharma, Inc. (VBIO) Statistics
Valuation metrics
Market Cap 6.01M
Enterprise value 24.16M
Trailing P/E (ttm) -0.04
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -56.81
Price/Book (mrq) 0.02
Enterprise Value/Revenue -154.9
Enterprise Value/EBITDA -1.52
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 6.76M
Average volume (90 days) 9.75M
Price summary
52-Week low 1.11
52-Week high 75.5
Beta -
50-Day moving average 2.15
200-Day moving average 1.07
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 31 Aug 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 120.19%
Operating margin 105.87%
Operational effectiveness
Return on assets -0.58%
Return on equity -1.65%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -1.15
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -138.68
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 15.59
Total debt (mrq) -
Total Debt/Equity (mrq) 1.46
Current ratio (mrq) 1.11%
Book value per share (mrq) 87.91
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
